IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 21,050
-1,050 (-4.75%)
At close: Jun 26, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 377.05 billion as of June 29, 2026. Its market cap has decreased by -40.66% in one year.
Market Cap
377.05B
Enterprise Value
359.85B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
21,050.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 377.05B, a decrease of -23.41%. That is a compound annual growth rate of -21.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 377.05B | -56.21% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 704.38B |
| Inventage Lab | 527.77B |
| Curocell | 424.80B |
| HansBiomed | 350.12B |
| IMBiologics | 299.78B |
| curacle co.,ltd. | 248.62B |
| S.Biomedics | 241.88B |
| Kangstem Biotech | 191.87B |